MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$13,819K
Net Income
-$22,864K
Net Profit Margin
-165.45%
EPS
-$0.18
Unit: Thousand (K) dollars
Revenue Breakdown
Manufacture And Supply Revenue
License And Royalty Revenue
Co Development And Research Fees
Revenue Breakdown
US
Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
13,819
14,446
13,015
12,807
Manufacture and supply
4,017
3,469
5,836
4,506
Research and development
3,962
4,204
3,196
4,530
Selling, general and administrative
14,063
10,977
32,822
15,250
Total costs and expenses
22,042
18,650
41,854
24,286
Loss from operations
-8,223
-4,204
-28,839
-11,479
Loss on extinguishment of debt
-11,683
-
-
-
Interest expense
2,807
2,903
2,778
2,779
Interest expense related to royalty obligations
972
973
1,433
1,433
Interest expense related to the sale of future revenue
61
60
62
61
Interest income and other income, net
882
83
1,252
306
Net loss before income taxes
-22,864
-8,057
-31,860
-15,446
Income taxes benefit
-
-
0
-
Net loss
-22,864
-8,057
-31,860
-15,446
Comprehensive loss
-22,864
-8,057
-31,860
-15,446
Basic EPS
-0.18
-0.07
-0.261
-0.14
Diluted EPS
-0.18
-0.07
-0.261
-0.14
Basic Average Shares
124,994,165
122,609,995
122,297,984
110,584,371
Diluted Average Shares
124,994,165
122,609,995
122,297,984
110,584,371
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Comprehensive loss
-$22,864K
(-68.76%↓ Y/Y)
Net loss
-$22,864K
(-68.76%↓ Y/Y)
Net loss before
income taxes
-$22,864K
(-68.76%↓ Y/Y)
Interest income and other
income, net
$882K
(-57.92%↓ Y/Y)
Manufacture And Supply
Revenue
$11,911K
(24.29%↑ Y/Y)
License And Royalty
Revenue
$1,326K
(58.05%↑ Y/Y)
Co Development And
Research Fees
$582K
(53.97%↑ Y/Y)
Loss on
extinguishment of debt
-$11,683K
Loss from operations
-$8,223K
(27.67%↑ Y/Y)
Interest expense
$2,807K
(0.93%↑ Y/Y)
Interest expense related
to royalty...
$972K
(-32.22%↓ Y/Y)
Revenues
$13,819K
(38.15%↑ Y/Y)
Interest expense related
to the sale of...
$61K
(0.00%↑ Y/Y)
Total costs and
expenses
$22,042K
(3.14%↑ Y/Y)
Selling, general and
administrative
$14,063K
(10.69%↑ Y/Y)
Manufacture and supply
$4,017K
(-11.93%↓ Y/Y)
Research and development
$3,962K
(-3.48%↓ Y/Y)
Buy us a coffee
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)